Yasuo Yoshioka
6PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jul 23, 2025
Modulating Immunogenicity and Reactogenicity in mRNA-Lipid Nanoparticle Vaccines through Lipid Component Optimization.Yoshino Kawaguchi, Mari Kimura, Tatsuya Karaki
|Oct 11, 2024
Recombinant RSV G protein vaccine induces enhanced respiratory disease via IL-13 and mucin overproduction.Eigo Kawahara, Kota Senpuku, Yoshino Kawaguchi
|Sep 26, 2024
Effect of Anti-PEG Antibody on Immune Response of mRNA-Loaded Lipid Nanoparticles.Daiki Omata, Eigo Kawahara, Lisa Munakata
|Jun 17, 2024
Lipid Nanoparticle with 1,2-Di-O-octadecenyl-3-trimethylammonium-propane as a Component Lipid Confers Potent Responses of Th1 Cells and Antibody against Vaccine Antigen.Atsushi Kawai, Masahiro Noda, Haruki Hirata
|Oct 06, 2022
Elucidation of the role of nucleolin as a cell surface receptor for nucleic acid-based adjuvants.Satoki Kitagawa, Teppei Matsuda, Ayaka Washizaki
|Dec 23, 2021
Neutrophil-Mediated Lung Injury Both via TLR2-Dependent Production of IL-1α and IL-12 p40, and TLR2-Independent CARDS Toxin after Mycoplasma pneumoniae Infection in Mice.Shigeyuki Tamiya, Eisuke Yoshikawa, Monami Ogura
Pageof 1
